Halozyme to Report Third Quarter 2025 Financial and Operating Results
Go back to Halozyme to Report Third Quarter 2025 Financial and Operating Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 102.54 +3.88 (3.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.66 | 52 Week High | $18.39 | |||
| Open | $98.86 | 52 Week Low | $6.96 | |||
| Day High | $102.66 | P/E | N/A | |||
| Day Low | $98.58 | EPS | $-0.58 | |||
| Volume | 383,641 | |||||
